Preliminary feasibility and clinical utility of the Unified Protocol for the transdiagnostic treatment of emotional disorders in people with long COVID-19 condition: A single case pilot study
- PMID: 40779512
- PMCID: PMC12334038
- DOI: 10.1371/journal.pone.0329595
Preliminary feasibility and clinical utility of the Unified Protocol for the transdiagnostic treatment of emotional disorders in people with long COVID-19 condition: A single case pilot study
Abstract
Purpose: The implementation of psychological interventions in long COVID-19 patients is still very limited. This study aims to analyze the feasibility and preliminary utility of the Unified Protocol (UP), for the psychological treatment of emotional disorders in long COVID-19 patients.
Methods: 12 long COVID-19 patients (mean age = 47.92; SD = 13.18) presenting emotional disorders/symptoms received the UP through 8 online sessions.
Results: All participants completed the UP psychological program, attending all eight sessions and the 6-month follow-up appointment. However, adherence to the assessment protocol was lower, with a 33% dropout rate at the 6-month follow-up. High satisfaction was reported with both the UP program (mean = 9.75) and the online format. Satisfaction with individual UP modules ranged from 7.17 to 9 points (from 0 = any satisfaction to 10 = highest satisfaction). Qualitative feedback emphasized the usefulness of the UP program, with some participants suggesting additional contents (i.e., training in assertive communication skills), more personalized modules (i.e., providing just some UP modules) or increasing the number of sessions. In terms of the UP clinical utility, 25 mental clinical diagnoses were established at pre-assessment; 50% of participants no longer met criteria for a mental clinical diagnosis at post-assessment, increasing to 67% at follow-up. Most therapeutic objectives were achieved or initiated over the course of the intervention (78% at post-assessment; 86% at follow-up). At post-assessment significant improvements were observed in anxiety (8 participants), depression (9 participants), emotion dysregulation (4 participants) and quality of life scores (7 participants), although 2 participants did not maintain these gains in emotion regulation and quality of life at follow-up.
Conclusion: The promising results of the UP in terms of high participant satisfaction and clinical improvements in anxiety and depression scores suggest that the UP could be a valuable psychological intervention for individuals with long COVID-19 and comorbid emotional disorders. The modest improvements found in other outcomes highlighted the need to better adapt the psychological interventions for long COVID-19 patients.
Copyright: © 2025 Martínez-Borba et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures
Similar articles
-
E-Health interventions for anxiety and depression in children and adolescents with long-term physical conditions.Cochrane Database Syst Rev. 2018 Aug 15;8(8):CD012489. doi: 10.1002/14651858.CD012489.pub2. Cochrane Database Syst Rev. 2018. PMID: 30110718 Free PMC article.
-
Psychological therapies for post-traumatic stress disorder and comorbid substance use disorder.Cochrane Database Syst Rev. 2016 Apr 4;4(4):CD010204. doi: 10.1002/14651858.CD010204.pub2. Cochrane Database Syst Rev. 2016. PMID: 27040448 Free PMC article.
-
Specialist breast care nurses for support of women with breast cancer.Cochrane Database Syst Rev. 2021 Feb 3;2(2):CD005634. doi: 10.1002/14651858.CD005634.pub3. Cochrane Database Syst Rev. 2021. PMID: 34559420 Free PMC article.
-
Music-based therapeutic interventions for people with dementia.Cochrane Database Syst Rev. 2025 Mar 7;3(3):CD003477. doi: 10.1002/14651858.CD003477.pub5. Cochrane Database Syst Rev. 2025. PMID: 40049590
-
Inhaled mannitol for cystic fibrosis.Cochrane Database Syst Rev. 2018 Feb 9;2(2):CD008649. doi: 10.1002/14651858.CD008649.pub3. Cochrane Database Syst Rev. 2018. Update in: Cochrane Database Syst Rev. 2020 May 1;5:CD008649. doi: 10.1002/14651858.CD008649.pub4. PMID: 29424930 Free PMC article. Updated.
References
-
- World Health Orgnization [WHO]. Areas of work. In: Communicable and noncommunicable diseases, and mental health [Internet]. 2024. Available from: https://www.who.int/our-work/communicable-and-noncommunicable-diseases-a...
-
- World Health Orgnization [WHO]. WHO Results Report Programme Budget 2018-2019: Driving impact in every country. World Health Organization; 2020. Available from: https://www.who.int/about/accountability/results/2018-2019/communicable-...
-
- World Health Orgnization [WHO]. World Health Statistics. In: SDG Target 3.3 Communicable diseases [Internet]. 2024. Available from: https://www.who.int/data/gho/data/themes/topics/sdg-target-3_3-communica...
-
- National Institute of Mental Health [NIH]. Chronic Illness and Mental Health: Recognizing and treating Depression. National Institute of Mental Heath; 2021. Available from: https://www.metrocareservices.org/wp-content/uploads/2023/10/recognizing...
-
- Bullis JR, Boettcher H, Sauer‐Zavala S, Farchione TJ, Barlow DH. What is an emotional disorder? A transdiagnostic mechanistic definition with implications for assessment, treatment, and prevention. Clin Psychol Sci Pract. 2019;26(2):e12278. doi: 10.1111/cpsp.12278 - DOI
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous